Qv Investors Inc. Novo Nordisk A S Transaction History

Qv Investors Inc.

$1.15 Billion
Q1 2024

A detailed history of Qv Investors Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Qv Investors Inc. holds 8,364 shares of NVO stock, worth $1.2 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

8,364

Previous 23,254 64.03%

Holding current value

$1.2 Million

Previous $2.41 Million 55.36%

% of portfolio

0.09%

Previous 0.22%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	SELL	$102.11 - $135.92 $1.52 Million - $2.02 Million	-14,890 Reduced 64.03%	8,364 $1.07 Million
Q4 2023 Jan 24, 2024	SELL	$87.78 - $105.45 $4.13 Million - $4.96 Million	-47,030 Reduced 66.91%	23,254 $2.41 Million
Q3 2023 Oct 23, 2023	BUY	$90.94 - $199.54 $1.87 Million - $4.11 Million	20,582 Added 41.41%	70,284 $6.39 Million
Q2 2023 Jul 25, 2023	SELL	$155.98 - $172.65 $332,237 - $367,744	-2,130 Reduced 4.11%	49,702 $8.04 Million
Q1 2023 May 01, 2023	SELL	$132.34 - $159.14 $781,203 - $939,403	-5,903 Reduced 10.22%	51,832 $8.25 Million

Q4 2022 Jan 20, 2023	BUY	$102.55 - $135.33 $70,759 - $93,377	690 Added 1.21%	57,735 $7.81 Million
Q3 2022 Oct 18, 2022	SELL	$95.28 - $116.93 $155,306 - $190,595	-1,630 Reduced 2.78%	57,045 $5.68 Million
Q2 2022 Jul 19, 2022	SELL	$103.24 - $121.81 $2.39 Million - $2.82 Million	-23,120 Reduced 28.27%	58,675 $6.54 Million
Q1 2022 Apr 20, 2022	SELL	$93.1 - $112.54 $135,926 - $164,308	-1,460 Reduced 1.75%	81,795 $9.08 Million
Q4 2021 Jan 18, 2022	SELL	$95.88 - $117.08 $5.44 Million - $6.64 Million	-56,740 Reduced 40.53%	83,255 $9.33 Million
Q3 2021 Oct 15, 2021	SELL	$84.42 - $106.62 $3.59 Million - $4.53 Million	-42,500 Reduced 23.29%	139,995 $13.4 Million
Q2 2021 Jul 19, 2021	SELL	$67.66 - $84.76 $372,806 - $467,027	-5,510 Reduced 2.93%	182,495 $15.3 Million
Q1 2021 Apr 16, 2021	SELL	$67.06 - $75.82 $896,592 - $1.01 Million	-13,370 Reduced 6.64%	188,005 $12.7 Million
Q4 2020 Jan 27, 2021	SELL	$63.89 - $73.8 $2.44 Million - $2.82 Million	-38,250 Reduced 15.96%	201,375 $14.1 Million
Q3 2020 Oct 14, 2020	SELL	$63.69 - $70.22 $1.69 Million - $1.87 Million	-26,610 Reduced 9.99%	239,625 $16.6 Million
Q2 2020 Jul 16, 2020	SELL	$58.54 - $67.94 $4 Million - $4.65 Million	-68,386 Reduced 20.44%	266,235 $17.4 Million
Q1 2020 Apr 24, 2020	SELL	$49.46 - $64.78 $3.13 Million - $4.11 Million	-63,379 Reduced 15.92%	334,621 $20.1 Million
Q4 2019 Jan 30, 2020	BUY	$49.86 - $58.26 $2.86 Million - $3.34 Million	57,320 Added 16.83%	398,000 $23 Million
Q3 2019 Oct 28, 2019	BUY	$47.54 - $53.43 $12.1 Million - $13.6 Million	254,360 Added 294.67%	340,680 $17.6 Million
Q2 2019 Jul 19, 2019	BUY	$46.79 - $52.47 $4.04 Million - $4.53 Million	86,320 New	86,320 $4.41 Million

Others Institutions Holding NVO

# of Institutions

1,862

Shares Held

309M

Call Options Held

5.29M

Put Options Held

4.93M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $323B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qv Investors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Qv Investors Inc. with notifications on news.

Account